Staphylococcus aureus (CIP 102182, NCTC 11561)
Staphylococcus aureus CIP 102182 is a bacterium of the family Staphylococcaceae.
genome sequence BacteriaName and taxonomic classification
| @ref 20215 |
Last LPSN update
2026-05-29 08:38:42 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus aureus |
| Full scientific name Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980) |
| Synonyms (2) |
Sequence information
Genome sequences
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|
| 66792 | 41315_E02 assembly for Staphylococcus aureus NCTC11561 | contig | GCA_900458105   | 1280.18096  | 1280 | 77.52 |  |
Genome browser: GCA_900458105
Literature
Literature 
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Re-purposing of domestic steam disinfectors within the hospital-at-home setting. | Millar BC, Stirling J, Maguire M, Moore RE, Murphy A, Moore JE. | Infect Dis Health | 10.1016/j.idh.2020.09.005 | 2021 | | |
| Genetics | Identification of an antibacterial protein by functional screening of a human oral metagenomic library. | Arivaradarajan P, Warburton PJ, Paramasamy G, Nair SP, Allan E, Mullany P. | FEMS Microbiol Lett | 10.1093/femsle/fnv142 | 2015 | |
| Pathogenicity | Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reports. | Cushnie TP, Hamilton VE, Lamb AJ. | Microbiol Res | 10.1078/0944-5013-00206 | 2003 | |
| Pathogenicity | A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota. | Wang M, Firrman J, Liu L, Yam K. | Biomed Res Int | 10.1155/2019/7010467 | 2019 | |
| Pathogenicity | In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens. | Aguilar L, Martin M, Balcabao IP, Gomez-Lus ML, Dal-Re R, Prieto J. | Antimicrob Agents Chemother | 10.1128/aac.41.6.1403 | 1997 | |
| Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate. | Thorburn CE, Molesworth SJ, Sutherland R, Rittenhouse S. | Antimicrob Agents Chemother | 10.1128/aac.40.12.2796 | 1996 | | |
| A STRATEGY FOR RAPID IDENTIFICATION OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS NASAL CARRIER STATUS. | Menon PK, Desai AB, Nagendra A. | Med J Armed Forces India | 10.1016/s0377-1237(02)80046-6 | 2002 | | |
| COMPARISON OF RAPID METHOD OF DNA EXTRACTION USING MICROWAVE IRRADIATION WITH CONVENTIONAL PHENOL CHLOROFORM TECHNIQUE FOR USE IN MULTIPLEX PCR FOR mec A AND fem B GENES TO IDENTIFY GENOTYPES OF MRSA FROM CULTURES. | Menon PK, Nagendra A. | Med J Armed Forces India | 10.1016/s0377-1237(01)80041-1 | 2001 | | |
| Molecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014). | Ceyssens PJ, Van Bambeke F, Mattheus W, Bertrand S, Fux F, Van Bossuyt E, Damee S, Nyssen HJ, De Craeye S, Verhaegen J, Belgian Streptococcus pneumoniae Study Group, Tulkens PM, Vanhoof R. | PLoS One | 10.1371/journal.pone.0154816 | 2016 | | |
| Pathogenicity | High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. | Gilbart J, Perry CR, Slocombe B. | Antimicrob Agents Chemother | 10.1128/aac.37.1.32 | 1993 | |
| Enzymology | In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. | Coleman K, Griffin DR, Page JW, Upshon PA. | Antimicrob Agents Chemother | 10.1128/aac.33.9.1580 | 1989 | |
| Pathogenicity | Kinetic study of interaction between BRL 42715, beta-lactamases, and D-alanyl-D-alanine peptidases. | Matagne A, Ledent P, Monnaie D, Felici A, Jamin M, Raquet X, Galleni M, Klein D, Francois I, Frere JM. | Antimicrob Agents Chemother | 10.1128/aac.39.1.227 | 1995 | |
| Pathogenicity | Antimicrobial spectrum of Ro 15-8074/001, a new oral cephalosporin. | Thomas MG, Lang SD. | Antimicrob Agents Chemother | 10.1128/aac.29.5.945 | 1986 | |
| Pathogenicity | Three decades of beta-lactamase inhibitors. | Drawz SM, Bonomo RA. | Clin Microbiol Rev | 10.1128/cmr.00037-09 | 2010 | |
| Interaction between methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA). | Gopal Rao G, Wong J | J Hosp Infect | 10.1016/s0195-6701(03)00287-1 | 2003 | | |
| Pathogenicity | The in-vitro activity of faropenem, a novel oral penem. | Woodcock JM, Andrews JM, Brenwald NP, Ashby JP, Wise R | J Antimicrob Chemother | 10.1093/jac/39.1.35 | 1997 | |
How to cite
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive136054.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain dataIsabel Schober, Julia Koblitz, Joaquim Sardà Carbasse, Christian Ebeling, Marvin Leon Schmidt, Adam Podstawka, Rohit Gupta, Vinodh Ilangovan, Javad Chamanara, Jörg Overmann, Lorenz Christian Reimer
Nucleic Acids Research; database issue 2025.
License